Business Wire

Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1%

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...
Reuters

Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal

May 21 (Reuters) - Mayne Pharma shares (MYX.AX), opens new tab posted their worst day in 16 years on Wednesday after U.S.-based Cosette Pharmaceuticals initiated a review of its A$672 million ($432.1 ...
NJBIZ

Cosette, Mayne Pharma terminate $430M acquisition deal

Bridgewater-based Cosette issued a statement Dec. 11 saying it served a notice to the Australia-headquartered pharmaceutical company two days prior terminating the agreement. The deal was originally ...
PharmTech

Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase

While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of ...
Hosted on MSN

Cosette Pharmaceuticals disagrees with Mayne Pharma's FIRB-related announcement

More news: Cosette Pharmaceuticals believes there are "material inaccuracies" in Mayne Pharma's response to reports regarding concerns its Salisbury manufacturing facility could be shuttered if ...
Business Wire

Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone ® 5%

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (“Cosette”), in partnership with SeegPharm SA (Lugano, Switzerland), is proud to announce the launch of Dapsone 5% Gel (NDC # ...